chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from an 81 year old retired registered nurse with arthritis and an allergy to injectable iodine who in approximately January 2008, "about 7 months ago," was vaccinated subcutaneously with a dose of ZOSTAVAX. The nurse stated that she developed pain at the injection site after her vaccination and the pain had continued to the present. The patient sought unspecified medical attention. Additional information has been requested.
Slight raised itchy bumps, starting 16-17 days post vaccines, no noted temp, no respiratory diff. S/S included on upper thighs bilateral extending to abdomen. No previous problems with vaccines. Father instructed to contact physician due to child's known history there. Father stated "no health insurance at present". Other list clinics offered.
Pt vaccinated with Recombivax developed mild urticaria reaction.  After 2nd dose, developed persistant urticaria & serum sickness, lasting now over 4 months. No resonse to steroids and antihistamines.
Patient state, one hour after vaccination, "I got the warm feeling, I got hot" Temp taken at 2 hour, no temp. Temp taken 4 hours later, no temp.
MAGNETS ARE STICKING TO ARM; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 17-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced magnets are sticking to arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of magnets are sticking to arm was not reported. This report was non-serious. This case, from the same reporter is linked to 20210603994.
About 24 hours after the vaccine, I developed chills, headache, fever, and fatigue. Those symptoms lasted for two days. I have COVID-19 now. I experienced the same symptoms, and I also have a cough. The 101-degree fever and chills stopped after two days. The headache lasted three days. I haven't lost my taste, but I have no desire to eat.
Red dots on face and right arm appeared after given MMR and influenza vaccines. The following day rash gone on face but still had lingering rash on right arm.
Patient has history of regular and consistent menstrual cycle until May 2021 (no previous history of irregular cycle or missing periods). Second dose of Pfizer covid vaccine was given May 8th and the patient has not had a menstrual cycle since. She has had amenorrhea for 4 full months at the time of reporting.
Immediately after the shot was given, child began to shiver, within a minute or so after eyes were dilated, and the child walked to her mother and said she could not see and lost all color. Seeing she was going to faint the nurses brought her to an exam room and she went limp and fainted. They sat her down. She came to and was administered a Pedialyte ice pop. Stayed about 10 minutes and color returned and was able to walk out. This child never had an adverse reaction to any other shot before.
rash on his arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on his arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced RASH (rash on his arm). At the time of the report, RASH (rash on his arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Followup information was received on 10 May 2021 in which event related details were updated.
I began to run fever and have chills and feel achy and that was about it. It began that afternoon about five hours after the shot and lasted through the night and a bit into the next morning. If I felt too bad I would lay down for awhile. I was completely recovered by the following morning, two days after the shot. I had the same reaction with all vaccinations including the Moderna.
got Stevens Johnson from the Pneumovax; This spontaneous report was received from a consumer referring via Pfizer to her husband, a male patient of unknown age. He was allergic to lidocaine (also reported as "actually any of the "-caines""). There was no information regarding his concomitant therapies provided.  On an unspecified date, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (dose, route of administration, anatomical location, lot # and expiration date were not provided) for prophylaxis. On an unknown date, he developed Stevens-Johnson syndrome. The outcome of the event was unknown.  The reporter considered the event to be related to the suspect vaccine.  Upon internal review, the event of Stevens-Johnson syndrome was considered to be medically significant.
On 4/21/2009, arm was sore and red at site of injection. Redness gradually worsened. At time indicated in number 11, patient began to feel nauseated. Later that day, arm very red and hot, fever developed (102.0 F) and felt achey all over. Antibiotics prescribed by physician for presumed cellulitis, began taking these at 5:30 PM on 4/22. At ~3:00 AM on 4/23, patient vomited. Loose stools and nausea have been experienced since that time, but no further vomiting. Patient has missed 1.5 days from work and probably will miss 4/24 also. Physician has indicated that IV antibiotics may be necessary.
This patient presented to hospital as a transfer where he has been hospitalized for the last week. He was admitted with complaints of respiratory distress. The patient is on home oxygen with 10 L of O2. He also has a home trilogy machine. Following his admission he continued to require high amounts of oxygen. He was on 100%/ 40L with a NRB as needed and then progressed to requiring Bipap most of the day and night. The patient was a DNR and the family was discussing end of life care with hospice. The patient was pronounced deceased at 1029 on 6/20/2023 with family at bedside.
This spontaneous report was received from a registered nurse, refers to a 20 year old female patient. The patient's pertinent medical history and drug reactions/allergies were unspecified by the reporter. Concomitant medications were reported as none. On an unknown date, the patient was vaccinated with first dose in the series of GARDASIL lot # L005560, expiry date 18-DEC-2016, 0.5 ml, intramuscularly. The nurse reported that the patient experienced "Bell's palsy" 2 weeks after receiving the first vaccination in the series of GARDASIL. She sought medical attention at hospital emergency room on 03-AUG-2015. Treatment was prescribed for the Bell's palsy described as "Prednisone and eye drops" while in the Emergency Room. No lab diagnostics studies were performed. She recovered on an unspecified date. The reporter did not provide the relatedness of the event with GARDASIL. No product quality complaint (PQC) was involved. No further information provided. Upon internal review "Facial paralysis" was determined to be medically significant. Additional information has been requested.
Patient had normal soreness in arm for the first couple of days following injection but the soreness has still not gone away. She reported back to Employee Health on 11/7/17 and was given a MEDROL Dose Pack to help. She has just contacted me and let me know that she is still in pain. She states that the pain runs down the front edge of her muscle. She can't lift her arm up above her head, and at times the pain has woken her up at night.
Itchy at injection site; Tiny rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy at injection site) and VACCINATION SITE RASH (Tiny rash at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Itchy at injection site) and VACCINATION SITE RASH (Tiny rash at injection site). At the time of the report, VACCINATION SITE PRURITUS (Itchy at injection site) and VACCINATION SITE RASH (Tiny rash at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Relevant concomitant medications was reported.  Treatment information was not provided.
This patient came for his COVID vaccine. He filled out the paper consent, checking "no" to if he had received a COVID vaccine previously. He was given a Pfizer vaccine with no adverse events this day. However, when we entered his information into the database, it was determined that he had received a Johnson & Johnson vaccine on 4/29/2021.
Pt received Hepatitis A injection at work place clinic on 10/3/2018, started having swelling, redness and a knot  at the injection site shortly after the injection. Area seemed to worsen over the next 2-3 weeks. He says he was treated with steriods and bactrim but no improvement. He has been seen by Dr.
Woke up unable to move my neck. Pain like broken glass in neck. Never experienced this kind of pain before.  Pain radiated down neck to right arm. Lessened with time but took a full month to dissipate.  It started after the first dose but was much milder.
sore arm first day, red and swelling. 2nd say,  sore joints, muscle aches, fever and swollen , red and hot injection site. 3 day to now , swollen, hot to the touch injection site.
Scratchy throat; Swelling in the back of the throat; A spontaneous report was received from a healthcare professional concerning a 47-years-old, female patient and who experienced scratchy throat and swelling in the back of throat.   The patient's medical history was not provided. Concomitant medications were not provided.   On 21 Dec 2020,  the patient received their first of two planned doses of mRNA-1273 (lot# 011-J208) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  The healthcare professional reported that 20 minutes after administering mRNA-1273 to the patient in the left arm on 21 Dec 2020, the patient experienced a scratchy throat and swelling in the back of the throat.  The patient was a health care professional herself and took diphenhydramine hydrochloride (Benadryl), which caused the symptoms to subside but not completely resolve.  Action taken with mRNA-1273 in response to the events was unknown.  The events, scratchy throat and swelling in the back of the throat, were considered resolving.  The reporter did not provide an assessment of causality for the events, scratchy throat and swelling in the back of the throat.; Reporter's Comments: This case concerns a 47 year old female subject, who experienced the unlisted events of throat irritation and pharyngeal swelling.  The events occurred on 21 DEC 2020,  20 minutes after first dose of IP. The events were treated with diphenhydramine hydrochloride (Benadryl) and was considered resolving. The events were considered related to IP due to temporal association. However, further clarifications are requested.
Hives, wheezing,SOB,itching, Tingling in tongue initially. 01/05/2021 Fever 100.8, headache and joint pain Treated with Albuterol inhaler and Benadryl 25mg x2
20 y/o male, ADSM, presents as a referral from clinic for chest pain after smallpox vaccine. Symptoms: Chest pain, fever, headache, general.
This case was reported by a healthcare professional and described the occurrence of stomach pain in a male subject of unspecified age who was vaccinated with ENGERIX B. Previous and/or concurrent vaccination included hepatitis B vaccine recombinant; given on 10 September 1997. On 1 October 2007 the subject received 2nd dose of ENGERIX B (unknown) and experienced stomach pain, headache, lethargy and inappropriate schedule of vaccine administered. At the time of reporting the outcome of the headache, stomachache and lethargy were unspecified.
Pt mother reports her Right Eye edema and urticaria.  right Eye edema  for 1 day and urticaria for 3 days even after administering Benedryl
BREAKTHROUGH COVID 19 INFECTION. REGEN OFFERED BUT NOT GIVEN AT TIME OF ENTRY HAS MILD SX
This spontaneous report as received from medical assistant refers to an unspecified number of patients of unknown age and gender. Pertinent medical history was unknown. The reporter stated that on an unknown date unspecified number of patients were inadvertently vaccinated with PNEUMOVAX 23 (dose, lot#, route of administration and anatomical location was unknown) that had been improperly stored. No adverse effects reported. The outcome of the events was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
45 mm area of redness and slight swelling on left arm just below deltoid area.  Complained of warmth and itching at site.  No systemic symptoms noted.  Cool compresses and visit to PMD advised.
4 days after her second shot, she was sitting at the lunch table and she became unresponsive.   She went into a coma and died 4 days later.  Doctor said she had a stroke.
Developed drooping check, crooked mouth, eyelid would not shut; diagnosed with Bells Palsy
03/23/2023 COVID-19 test positive. I had the feeling of having a head cold no other symptoms. I contacted clinic and was given a prescription for Paxlovid. I am feeling better, but I have noticed that my energy levels are not what they were before COVID-19.
SWELLING IN SPINE; INCREASED HEART RATE WHICH GOT WORSE WITH PHYSICAL ACTIVITY; PAIN IN LOWER PART OF BOTH LEGS; TINGLING IN LOWER PART OF LEGS/TINGLING IN TOES; HEADACHE; This spontaneous report received from a patient concerned a 40 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included alcohol use, and non-smoker, and other pre-existing medical conditions included no known allergies, no history of drug abuse or illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 09-APR-2021, the subject experienced headache. On 23-APR-2021, the subject experienced tingling in lower part of legs/tingling in toes. On 23-APR-2021, the subject experienced increased heart rate which got worse with physical activity. On 23-APR-2021, the subject experienced pain in lower part of both legs. On MAY-2021, Laboratory data included: Blood test (NR: not provided) Unspecified, MRI brain (NR: not provided) Unspecified, and Magnetic resonance imaging spinal (NR: not provided) Unspecified. On 03-MAY-2021, the subject experienced swelling in spine. Treatment medications (dates unspecified) included: prednisone. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from increased heart rate which got worse with physical activity on 28-MAY-2021, and headache on 23-APR-2021, was recovering from pain in lower part of both legs, and tingling in lower part of legs/tingling in toes, and had not recovered from swelling in spine. This report was non-serious.
Received an expired booster dose; Similar to the first but less severe (body pain); Similar to the first but less severe (Fever); This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Similar to the first but less severe (body pain)), PYREXIA (Similar to the first but less severe (Fever)) and EXPIRED PRODUCT ADMINISTERED (Received an expired booster dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 066F21A, 029A21A and 001C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Received an expired booster dose). In December 2021, the patient experienced PAIN (Similar to the first but less severe (body pain)) and PYREXIA (Similar to the first but less severe (Fever)). On 03-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Received an expired booster dose) had resolved. At the time of the report, PAIN (Similar to the first but less severe (body pain)) and PYREXIA (Similar to the first but less severe (Fever)) outcome was unknown.            Patient experienced events less severe than the first dose. No relevant concomitant medications were reported. No treatment information was provided.   This case was linked to MOD-2022-441836, MOD-2022-441951 (Patient Link).
This case was reported by a healthcare professional and described the occurrence of shortness of breath in a 73-year-old subject of unspecified gender who was vaccinated with Flulaval for prophylaxis. Concurrent medications were not specified. On an unspecified date (15 November 2007 or later) the subject received 1st dose of Flulaval (unknown) with expiration date March 2008. In November 2007, at an unspecified time after vaccination with Flulaval, the subject experienced shortness of breath, fever, weakness and vomiting. The reaction was classified as systemic. The healthcare professional considered the events were disabling. The reporter suspected a safety and quality issue (product complaint) with the vaccine. At the time of reporting the outcome of the events was unspecified. It was indicated that these events occurred with multiple subjects. Nine specified at the time of the report. It was noted that 2 or 3 subjects had to be treated in the emergency room for these events. Most of the subjects recovered from the events after 2 to 4 days. Some subjects had not yet recovered at the time of reporting. Specifics on each individual subject were not provided.
Patient stated she was feeling well today. Received flu vac, shortly after she sat in waiting area saying she felt dizzy. We offered assistance and food. She went home, we called to make sure she was doing  two hours later. Husband said she was resting
Information has been received from a physician concerning a 17 year old female who on 24-SEP-2007 was vaccinated with her first dose of GARDASIL vaccine (yeast). The patient developed erythema nodosum on her legs which lasted for over one month. On 23-Nov-2007, the patient received her second dose of GARDASIL vaccine (yeast). Subsequently the patient experienced erythema nodosum on her legs again. The patient received the influenza virus vaccine (unspecified) (INFLUENZA VIRUS VACCINE USP) on 22-Oct-2007. The patient sought unspecified medical treatment in the office. No treatment required for either AE. The patient's erythema nodosum persisted. Additional information has been requested. Information has been received from a physician concerning a 17 year old female who on 24-SEP-2007 was vaccinated with her first dose of HPV vaccine. The patient developed erythema nodosum on her legs which lasted for over one month. On 23-Nov-2007, the patient received her second dose of HPV vaccine (lot # 658560/1062U) IM in the left deltoid. Subsequemtly the patient experienced erythema nodosum on her legs again. The patient received the influenza virus vaccine (unspecified) on 22-Oct-2007. The patient sought unspecified medical treatment in the office. No treatment required for eith AE. The patient's erythema nodisum persisted. Follow-up information was received from the physician. Illness at the time of vaccination was erythema nodosum. "Bruises" on lower legs with erythema nodosum on the exam. The patient reported getting lesions in October 2007, one month post first HPV vaccine dose. The patient was seen in November 2007 and was given a second dose of HPV vaccine. The patient reported worsening/increase in lesions after the second dose. A complete blood cell count prothrombin time and activated partial thromboplastin was performed and were normal. On an unspecified date the patient recovered as per telephone conversation 19-DEC-2007. Additional information is not expected.
Pt's wife and patient reported the right upper arm swelled to point of obliterating the landmarks of the right elbow. Also arm was very tender. Pt also reported ringing in both ears since getting vaccinated.
Initial unsolicited report received from other non-healthcare professional on 18-JAN-2017. This case involves a male patient (Age was not reported) who was vaccinated with a dose of FLU VACCINE (dose, dose in series, batch number, expiry date, route and site of administration were not reported) on an unspecified date. The patient's medical history and concomitant medications were not reported. On an unspecified date, following vaccination the patient was diagnosed with probable influenza by personal physician. Laboratory data and corrective treatment were not reported. Outcome of event was not reported. Upon internal review, the company decided to consider the event serious because of important medical event Influenza. List of documents held by sender: none. Sender's Comments: As with any other vaccine influenza vaccine may not protect 100% of individuals. Manufacturer of the vaccine was not provided. This is poorly documented case. However, investigation results ruling out a concurrent condition and other etiologies would be helpful to further assess this case.
ABOUT 1 WEEK AFTER PATIENT RECEIVED ZOSTAVAX IMMUNIZATION SHE DEVELOPED A RASH ON VARIOUS PARTS OF HER BODY. THERE WAS A VESICULAR RASH ON HER RIGHT INNER THIGH WITH LOTS OF TINGLING. ALSO HAD A VESICULAR RASH ON HER BACK, UPPER CHEST, AND RIGHT FOREARM. SHE DID NOT REPORT THE RASH TO THE MEDICIAL CLINIC UNTIL ABOUT 3 WEEKS AFTER IT HAD ALREADY DEVELOPED. SHE WAS DIAGNOSED WITH DISSEMINATED HERPES ZOSTER.
w/in 5 mins of vax pt exp syncope w/brief twitching of limbs; unconscious 5-10 seconds, vomited 1-2 hrs later, t103 ax, diarrhea, 2-3 days; MD advised sxs wnl 18jul - syncope w/ twitching; while standing 31aug syncope w/ twitching;
Patient reports having pain on the injection site since the day of vaccination. Patient said the pain is relieved by Advil and pain is getting better.
Today, Patient informed us that after She got her 1st Dose on 08/07/2021, She had the  CHEST PAIN once reached home almost 45 mins after the shot. Intense Pain for 30 sec then gradually  decreased it. She said pain stayed for around 6 hours and after that She was perfectly fine.  Patient was in touch with her PCP during this time and was following the direction given by her Dr.
Overnight, my (almost 19) son did not wake me, but reported to me in the morning that he had headaches, chills, numbness, thirst, and hallucinations. He was aware that they were not real during and after he had them, but it was a nonetheless disturbing experience.  He described to me having the need to hydrate all night and he drank a lot of water. This morning he was still having a headache and numbness as well as overall malaise, but has taken advil and eaten a light breakfast. He is dressed and up and around and seems to be improving. Should the symptoms return or worsen, we plan to take him for medical care.
(L) arm localized redness and itching. NP instructed patient to take TYLENOL and BENADRYL and to return with worsening of symptoms.